FDA.reportPublic FDA data

dantrolene sodium 250 MG Injection

RxCUI
1544753
RxNorm name
dantrolene sodium 250 MG Injection
Display name
dantrolene sodium 250 MG Injection
Full name
dantrolene sodium 250 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RYANODEX dantrolene sodiumDANTROLENE SODIUMEagle Pharmaceuticals, Inc.8f7b3ac0-604d-4c78-b545-5e0f8ea3d6982024-10-30Warnings, Adverse reactionsExact identifier
rxcui: 1544753

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8f7b3ac0-604d-4c78-b545-5e0f8ea3d698dantrolene sodium 250 MG Injection [PSN] · dantrolene sodium 250 MG Injection [SCD]210These highlights do not include all the information needed to use RYANODEX safely and effectively. See full prescribing information for RYANODEX. RYANODEX ® (dantrolene sodium) for injectable suspension, for intravenous use. Initial U.S. Approval: 197420241030